Myostatin: Regulator of Muscle Wasting in Heart Failure and Treatment Target for Cardiac Cachexia

Circulation- United States

doi 10.1161/cir.0b013e3181d0ba8b

Full Text

Abstract

Available in

Date

Authors

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Predictive Value of Cardiac Cachexia in Chronic Heart Failure

Cardiovascular Therapy and Prevention (Russian Federation)
Cardiovascular MedicineCardiology
2016English

Targeting RAGE Prevents Muscle Wasting and Prolongs Survival in Cancer Cachexia

Journal of Cachexia, Sarcopenia and Muscle
OrthopedicsSports MedicinePhysiology
2020English

Eicosapentaenoic Acid and Oxypurinol in the Treatment of Muscle Wasting in a Mouse Model of Cancer Cachexia

PLoS ONE
Multidisciplinary
2012English

Pathogenesis of Muscle Wasting in Cancer Cachexia: Targeted Anabolic and Anticatabolic Therapies

Current Opinion in Clinical Nutrition and Metabolic Care
MedicineNutritionDietetics
2010English

Muscle Wasting and Sarcopenia in Heart Failure: A Brief Overview of the Current Literature

ESC heart failure
Cardiovascular MedicineCardiology
2018English

The Countermeasure for Cancer Cachexia Related Muscle Wasting Does Not Need to Be Muscle Hyperplasia

Acta Physiologica
Physiology
2019English

Harnessing Cardiac Energetics in the Treatment of Heart Failure

Indian Journal of Cardiovascular Disease in Women WINCARS
2016English

Neuromuscular Junction Fragmentation and Muscle Wasting in Heart Failure: A Sharp Cut From a Sica Sword?

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2015English

Valvular Heart Diseases (7). Result of Cardiac Operation for Valvular Heart Disease With Cardiac Cachexia.

Japanese Journal of Cardiovascular Surgery
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy